BIOG B logo

BioGaia AB (publ) Stock Price

OM:BIOG B Community·SEK 11.8b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 21 Fair Values set on narratives written by author

BIOG B Share Price Performance

SEK 116.90
11.30 (10.70%)
SEK 165.00
Fair Value
SEK 116.90
11.30 (10.70%)
29.2% undervalued intrinsic discount
SEK 165.00
Fair Value
Price SEK 116.90
AnalystConsensusTarget SEK 165.00

BIOG B Community Narratives

·
Fair Value SEK 165 29.2% undervalued intrinsic discount

Expanding North American Demand Will Unlock New Health Trends

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative

Trending Discussion

Updated Narratives

BIOG B logo

BIOG B: Dividend Strength And Skincare Expansion Will Support Future Rerating

Fair Value: SEK 165 29.2% undervalued intrinsic discount
13 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
3 Rewards

BioGaia AB (publ) Key Details

SEK 1.5b

Revenue

SEK 417.5m

Cost of Revenue

SEK 1.1b

Gross Profit

SEK 795.0m

Other Expenses

SEK 332.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 17, 2026
3.28
72.97%
21.49%
0%
View Full Analysis

About BIOG B

Founded
1990
Employees
243
CEO
Theresa Agnew
WebsiteView website
www.biogaiagroup.com

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.

Recent BIOG B News & Updates

Narrative Update Jun 23

BIOG B: Dividend Strength And Skincare Expansion Will Support Future Rerating

Analysts have trimmed their price target on BioGaia to SEK165. This reflects a slightly higher discount rate and modestly adjusted long term assumptions following more cautious recent research.
Analysis Article Jun 21

BioGaia (OM:BIOG B) Stock Could Be 28.4% Undervalued After Skincare Expansion

BioGaia (OM:BIOG B) has drawn fresh investor attention after expanding its BioGaia Skincare portfolio with two microbiome-focused products for babies and children, along with updated packaging and recent launches in China and the US. See our latest analysis for BioGaia. The new skincare launches arrive after a mixed period for BioGaia’s stock, with the share price at SEK118.2, a 30 day share price return down 9.7% but a year to date share price return of 12.57% and a 1 year total shareholder...

Recent updates

No updates